from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1349/irtB

LFCtreatmentdescriptionclass of inhibitor

-0.773

Amikacinug/mL Amikacintranslation

0.482

Cap5-10ug/mL Capreomycintranslation

0.277

Rox10-50 ug/mL Roxithromycintranslation

-0.229

SM2-5 ug/mL Streptomycintranslation

-1.765

Tet5-10 ug/mL Tetracyclinetranslation

0.019

Rif0.2-5ug/mL Rifampicintranscription

0.331

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.439

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.069

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.595

CPZ10-50 ug/mL Chlorpromazinerespiration

3.018

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.444

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.489

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.387

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.258

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.750

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.019

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.621

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.639

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.744

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.621

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.807

Nigericin50 uM Nigericinrespiration

-0.222

TRC10-150 ug/mL Triclosanrespiration

0.018

TRZ10-25 ug/mL Thioridazinerespiration

1.189

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.210

menadione6-10 ug/mL Menadionerespiration

2.178

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.396

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.408

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.383

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.050

NRP_1Non-replicating persistence stage 1dosRassociated

0.254

Amp0.2mg/mL AmpicillincellWall

-0.474

Cephalexin20-100 ug/mL CephalexincellWall

0.850

Cerulenin0.32-5 ug/mL CerulenincellWall

0.111

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.134

EMB10-20 ug/mL EthambutolcellWall

-0.222

Eta12-40 ug/mL EthionamidecellWall

0.030

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.099

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.369

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.112

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.268

BZA0.12 mg/mL BenzamidearomaticAmides

-0.272

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.253

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.138

H2O24 mM hydrogen peroxideDNAdamaging

-0.019

Levo10 ug/mL LevofloxacinDNAdamaging

-0.145

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.360

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.027

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.028

UVUV-irradiationDNAdamaging

0.468

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.349

Antimycin12.5-50 ug/mL Antimycin A?

-0.585

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.129

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.455

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.968

PA8240.2-2 ug/mL PA-824?

0.214

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.129

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.600

Verapamil50 uM Verapamil?

-0.709

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.459

methoxatin10-20 ug/mL Methoxatin?